INVIVO EVALUATION OF A-56619 (DIFLOXACIN) AND A-56620 - NEW ARYL-FLUOROQUINOLONES

被引:38
作者
FERNANDES, PB [1 ]
CHU, DTW [1 ]
BOWER, RR [1 ]
JARVIS, KP [1 ]
RAMER, NR [1 ]
SHIPKOWITZ, N [1 ]
机构
[1] ABBOTT LABS,DIV PHARMACEUT PROD,N CHICAGO,IL 60064
关键词
D O I
10.1128/AAC.29.2.201
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:201 / 208
页数:8
相关论文
共 9 条
[1]   ENTEROCOCCAL SUPERINFECTION AND COLONIZATION WITH AZTREONAM THERAPY [J].
CHANDRASEKAR, PH ;
SMITH, BR ;
LEFROCK, JL ;
CARR, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (02) :280-282
[2]   COMPARISON OF THE ANTIBACTERIAL ACTIVITY OF NORFLOXACIN (MK 0366, AM 715), A NEW ORGANIC-ACID, WITH THAT OF OTHER ORALLY ABSORBED CHEMOTHERAPEUTIC-AGENTS [J].
GADEBUSCH, HH ;
SHUNGU, DL ;
WEINBERG, E ;
CHUNG, SK .
INFECTION, 1982, 10 (01) :41-44
[3]   PHARMACOKINETIC STUDIES OF NORFLOXACIN IN LABORATORY-ANIMALS [J].
GILFILLAN, EC ;
PELAK, BA ;
BLAND, JA ;
MALATESTA, PF ;
GADEBUSCH, HH .
CHEMOTHERAPY, 1984, 30 (05) :288-296
[4]   TRIMMED SPEARMAN-KARBER METHOD FOR ESTIMATING MEDIAN LETHAL CONCENTRATIONS IN TOXICITY BIOASSAYS [J].
HAMILTON, MA ;
RUSSO, RC ;
THURSTON, RV .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 1977, 11 (07) :714-719
[5]   INVITRO ANTI-BACTERIAL ACTIVITY OF AM-715, A NEW NALIDIXIC-ACID ANALOG [J].
ITO, A ;
HIRAI, K ;
INOUE, M ;
KOGA, H ;
SUZUE, S ;
IRIKURA, T ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (02) :103-108
[6]  
MOELLERING RC, 1982, REV INFECT DIS, V4, pS708
[7]   ABSORPTION, DISTRIBUTION, METABOLIC-FATE, AND ELIMINATION OF PEFLOXACIN MESYLATE IN MICE, RATS, DOGS, MONKEYS, AND HUMANS [J].
MONTAY, G ;
GOUEFFON, Y ;
ROQUET, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (04) :463-472
[8]  
REED L. J., 1938, AMER JOUR HYG, V27, P493
[9]  
STAMM JM, 1985, ANTIMICROBIAL AGENTS, V29, P193